| 2025-09-29 | +93.3% | news | 24/7 Wall St. | These Penny Stocks are Soaring Today: DFLI, YCBD, PSTV - 24/7 Wall St. |
| 2025-12-12 | +91.4% | news | TipRanks | Here’s Why CbdMD Stock (YCBD) Rocketed Today - TipRanks |
| 2025-12-12 | +91.4% | news | StocksToTrade | cbdMD’s Bright Future: Stock Insights - StocksToTrade |
| 2025-12-12 | +91.4% | news | timothysykes.com | YCBD’s Market Surge: Diving into the Numbers - timothysykes.com |
| 2026-01-29 | +38.4% | legal | PR Newswire | cbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways |
| 2026-01-29 | +38.4% | news | Stock Titan | cbdMD doubles down on safety data as health rules on cannabinoids evolve - Stock Titan |
| 2025-12-17 | +35.3% | news | Stock Titan | CBD brand cbdMD schedules Dec. 19 call to review its 2025 results - Stock Titan |
| 2025-12-17 | +35.3% | news | TipRanks | Why Is CbdMD Stock (YCBD) Up Again Today? - TipRanks |
| 2025-12-18 | -34.8% | news | StocksToTrade | Surge of YCBD: Rocket or Risk? - StocksToTrade |
| 2025-01-03 | +32.7% | news | Seeking Alpha | cbdMD receives NYSE non-compliance notice |
| 2025-01-03 | +32.7% | legal | SEC EDGAR | YCBD 8-K: 3.01, 8.01 (SEC Filing) |
| 2025-01-03 | +32.7% | news | Stock Titan | cbdMD Faces NYSE American Delisting Risk Over $2M Equity Requirement Shortfall - Stock Titan |
| 2025-12-19 | -30.3% | earnings | Seeking Alpha | cbdMD, Inc. (YCBD) Q4 2025 Earnings Call Transcript |
| 2025-12-19 | -30.3% | news | PR Newswire | cbdMD, Inc. Announces Closing of $2.25 Million Series C Preferred Stock Private Placement - PR Newswire |
| 2025-12-19 | -30.3% | legal | marketscreener.com | CbdMD Insider Sold Shares Worth $1,276,842, According to a Recent SEC Filing - marketscreener.com |
| 2025-10-06 | +27.6% | legal | SEC EDGAR | YCBD 8-K: 1.01, 3.02, 5.03 (SEC Filing) |
| 2025-10-06 | +27.6% | news | Investing.com | cbdMD issues $1.7 million in Series B preferred stock to institutional investors By Investing.com - Investing.com |
| 2022-06-23 | -24.1% | legal | SEC EDGAR | YCBD 8-K: 1.01 (SEC Filing) |
| 2023-04-19 | -21.1% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2021-05-12 | -20.9% | legal | SEC EDGAR | YCBD 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-05-17 | +20.7% | legal | SEC EDGAR | YCBD 8-K: 3.02 (SEC Filing) |
| 2022-05-17 | +20.7% | legal | SEC EDGAR | YCBD 8-K: 5.02 and (SEC Filing) |
| 2022-05-17 | +20.7% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2025-04-10 | -18.8% | news | TMX Newsfile | cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting - TMX Newsfile |
| 2025-02-14 | -18.5% | earnings | Seeking Alpha | cbdMD targets growth with new product launches and improved profitability in Q1 2025 |
| 2025-02-14 | -18.5% | earnings | Seeking Alpha | cbdMD, Inc. (YCBD) Q1 2025 Earnings Call Transcript |
| 2025-09-30 | -18.1% | news | Seeking Alpha | Cannabis stocks rally after Trump posts video touting CBD use for senior healthcare |
| 2026-02-18 | +17.2% | earnings | Moby | cbdMD, Inc. Q1 2026 Earnings Call Summary |
| 2026-02-18 | +17.2% | earnings | GuruFocus.com | cbdMD Inc (YCBD) Q1 2026 Earnings Call Highlights: Strategic Acquisitions and Financial ... |
| 2023-03-17 | -17.1% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2022-07-18 | +16.9% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2025-08-14 | -16.7% | earnings | Seeking Alpha | cbdMD GAAP EPS of -$0.21, revenue of $4.6M |
| 2025-04-11 | -16.4% | legal | SEC EDGAR | YCBD 8-K: 5.07, 8.01 (SEC Filing) |
| 2025-02-13 | -16.3% | earnings | Seeking Alpha | cbdMD GAAP EPS of -$0.22 beats by $0.15, revenue of $5.11M misses by $0.08M |
| 2022-06-01 | -16.2% | legal | SEC EDGAR | YCBD 8-K: 8.01 and (SEC Filing) |
| 2024-08-19 | +15.2% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2022-06-03 | -15.0% | legal | SEC EDGAR | YCBD 8-K: 5.02 (SEC Filing) |
| 2025-01-08 | +14.4% | news | Seeking Alpha | cbdMD announces additional conversions of its convertible notes |
| 2023-04-14 | -13.1% | legal | SEC EDGAR | YCBD 8-K: 8.01 and (SEC Filing) |
| 2024-12-18 | -12.7% | earnings | Seeking Alpha | cbdMD GAAP EPS of -$1.79 beats by $0.84, revenue of $19.48M misses by $0.25M |
| 2024-02-13 | -11.8% | earnings | Seeking Alpha | cbdMD GAAP EPS of -$0.67 beats by $0.07, revenue of $5.38M misses by $0.42M |
| 2022-04-13 | -11.6% | legal | SEC EDGAR | YCBD 8-K: 1.01 (SEC Filing) |
| 2023-06-26 | -11.3% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2021-12-03 | -10.8% | legal | SEC EDGAR | YCBD 8-K: 5.02 and (SEC Filing) |
| 2026-02-15 | +10.5% | earnings | Seeking Alpha | cbdMD Q1 Earnings Preview |
| 2022-06-14 | +10.3% | legal | SEC EDGAR | YCBD 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-12-21 | -9.9% | news | StocksToTrade | cbdMD Stock Declines Post Insider Activity and Series C Closing - StocksToTrade |
| 2025-12-21 | -9.9% | news | timothysykes.com | cbdMD Stock Faces New Challenges with Recent Market Developments - timothysykes.com |
| 2024-07-16 | +9.4% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2022-06-17 | -9.1% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2025-12-22 | +8.9% | news | Benzinga | Stock Market Today: Dow Jones, S&P 500 Futures Climb At The Start Of Christmas Week— Kemper, Trump Media - Benzinga |
| 2026-02-02 | -8.8% | news | PR Newswire | cbdMD's Herbal Oasis Expands into Louisiana with Morales Beverage Group Following Strong Texas Momentum |
| 2022-03-02 | -8.5% | legal | SEC EDGAR | YCBD 8-K: 3.02 (SEC Filing) |
| 2022-04-18 | -8.3% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2026-04-23 | +8.2% | news | StocksToTrade | YCBD Stock Volatile As Traders Target CBD Microcap - StocksToTrade |
| 2026-04-23 | +8.2% | news | timothysykes.com | YCBD Stock Pops On Surge In Volume And Volatility - timothysykes.com |
| 2026-04-23 | +8.2% | news | StocksToTrade | YCBD Stock Pops On Heavy Volume As Traders Hunt Volatility - StocksToTrade |
| 2026-04-23 | +8.2% | news | timothysykes.com | YCBD Stock Jumps On Surging Volume As Traders Eye Turnaround - timothysykes.com |
| 2023-02-07 | -7.8% | legal | SEC EDGAR | YCBD 8-K: 1.01, 3.02 (SEC Filing) |
| 2026-04-20 | +7.7% | news | UBND thành phố Hải Phòng | cbdMD (YCBD) Stock Borrow Rate (Momentum Building) 2026-04-20 - Crowd Breakout Signals - UBND thành phố Hải Phòng |
| 2025-11-28 | +7.6% | legal | SEC EDGAR | YCBD 8-K: 5.02 and (SEC Filing) |
| 2023-12-22 | +7.3% | earnings | Seeking Alpha | cbdMD GAAP EPS of -$13.32, revenue of $24.16M |
| 2023-01-23 | +6.9% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2022-10-24 | +6.7% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for cbdMD (YCBD) - Zacks Investment Research |
| 2025-01-15 | +6.7% | legal | SEC EDGAR | YCBD 8-K: 8.01 and (SEC Filing) |
| 2023-05-15 | -6.6% | earnings | Seeking Alpha | cbdMD, Inc. (YCBD) Q2 2023 Earnings Call Transcript |
| 2023-05-15 | -6.6% | earnings | Seeking Alpha | cbdMD GAAP EPS of -$1.74, revenue of $6.58M |
| 2021-07-02 | -6.3% | legal | SEC EDGAR | YCBD 8-K: 8.01 and (SEC Filing) |
| 2021-07-27 | +6.2% | legal | SEC EDGAR | YCBD 8-K: 1.01, 5.02, 7.01 (SEC Filing) |
| 2024-02-02 | -6.1% | news | Seeking Alpha | cbdMD announces financing of $1.25M |
| 2024-02-02 | -6.1% | legal | SEC EDGAR | YCBD 8-K: 1.01, 3.02 (SEC Filing) |
| 2021-12-17 | +6.0% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2021-11-15 | -5.9% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2021-07-19 | +5.7% | legal | SEC EDGAR | YCBD 8-K: 8.01 and (SEC Filing) |
| 2022-01-18 | +5.6% | legal | SEC EDGAR | YCBD 8-K: 5.02 and (SEC Filing) |
| 2024-03-18 | +5.6% | legal | SEC EDGAR | YCBD 8-K: 1.01 and (SEC Filing) |
| 2026-02-12 | -5.6% | news | PR Newswire | cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results |
| 2026-02-12 | -5.6% | news | Stock Titan | Investors get Feb. 17 peek at cbdMD first-quarter results, 4:20 p.m. ET - Stock Titan |
| 2021-08-12 | -5.5% | legal | SEC EDGAR | YCBD 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-01-19 | -5.5% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2022-03-16 | +5.5% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2022-03-16 | +5.5% | legal | SEC EDGAR | YCBD 8-K: 5.07 and 8.01 (SEC Filing) |
| 2022-11-16 | -5.4% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2022-10-20 | +5.2% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2024-04-02 | +5.2% | legal | SEC EDGAR | YCBD 8-K: 5.02, 5.07and8.01 (SEC Filing) |
| 2024-08-15 | -5.0% | earnings | Seeking Alpha | cbdMD reports Q3 results |
| 2024-08-15 | -5.0% | earnings | Seeking Alpha | cbdMD, Inc. (YCBD) Q3 2024 Earnings Call Transcript |
| 2024-08-15 | -5.0% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2021-10-19 | +4.9% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2021-05-18 | +4.6% | legal | SEC EDGAR | YCBD 8-K: 3.02 (SEC Filing) |
| 2021-05-18 | +4.6% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2024-12-23 | -4.5% | legal | SEC EDGAR | YCBD 8-K: 5.02 and (SEC Filing) |
| 2022-01-07 | +4.4% | legal | SEC EDGAR | YCBD 8-K: 5.02 (SEC Filing) |
| 2023-02-22 | +4.4% | legal | SEC EDGAR | YCBD 8-K: 5.07 and 8.01 (SEC Filing) |
| 2023-02-22 | +4.4% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2024-03-03 | -4.3% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2025-05-15 | -4.2% | earnings | Seeking Alpha | cbdMD, Inc. (YCBD) Q2 2025 Earnings Call Transcript |
| 2025-05-15 | -4.2% | earnings | Seeking Alpha | cbdMD GAAP EPS of -$1.90, revenue of $4.75M |
| 2022-06-13 | +4.1% | legal | SEC EDGAR | YCBD 8-K: 8.01 and (SEC Filing) |
| 2024-08-13 | -4.0% | earnings | Seeking Alpha | cbdMD Q3 Earnings Preview |
| 2025-04-21 | +3.8% | news | Yahoo Finance | cbdMD, Inc. Announces Automatic Conversion Date of Series A Preferred Stock and One for Eight Reverse Split of its Common Stock Immediately Following the Automatic Conversion - Yahoo Finance |
| 2021-12-28 | -3.7% | legal | SEC EDGAR | YCBD 8-K: 3.02 (SEC Filing) |
| 2024-08-26 | +3.5% | news | Seeking Alpha | cbdMD announces acceptance of compliance plan by NYSE American |
| 2024-08-26 | +3.5% | legal | SEC EDGAR | YCBD 8-K: 3.01, 8.01 (SEC Filing) |
| 2024-08-29 | +3.5% | legal | SEC EDGAR | YCBD 8-K: 1.01 and 3.02 (SEC Filing) |
| 2025-08-20 | +3.4% | analyst | Quiver Quantitative | YCBD | cbdMD, Inc. Common Stock Analyst Forecasts - Quiver Quantitative |
| 2025-05-20 | -3.3% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2024-11-27 | -3.3% | legal | SEC EDGAR | YCBD 8-K: 1.01, 2.03, 8.01 (SEC Filing) |
| 2023-03-02 | -3.2% | legal | SEC EDGAR | YCBD 8-K: 1.01, 3.02, 5.02 (SEC Filing) |
| 2023-05-03 | -3.0% | legal | SEC EDGAR | YCBD 8-K: 1.01, 8.01 (SEC Filing) |
| 2025-10-01 | -2.9% | news | Stock Titan | $1.7M Capital Raise: CBD Wellness Leader cbdMD Strengthens Balance Sheet with Strategic Investment - Stock Titan |
| 2023-08-22 | +2.9% | news | Seeking Alpha | cbdMD suspends monthly dividend payment on series A cumulative convertible preferred stock |
| 2023-08-22 | +2.9% | legal | SEC EDGAR | YCBD 8-K: 8.01 and (SEC Filing) |
| 2023-08-22 | +2.9% | news | Yahoo Finance | cbdMD, Inc. Suspends Monthly Dividend Payment on Its Series A Cumulative Convertible Preferred Stock - Yahoo Finance |
| 2026-01-14 | -2.7% | M&A | Seeking Alpha | cbdMD acquires Bluebird Botanicals in all-equity asset deal |
| 2026-01-14 | -2.7% | legal | SEC EDGAR | YCBD 8-K: 1.01, 3.02 (SEC Filing) |
| 2026-01-14 | -2.7% | news | Stock Titan | Leading CBD innovator cbdMD buys longtime brand Bluebird Botanicals - Stock Titan |
| 2026-04-18 | +2.5% | news | Cổng thông tin điện tử tỉnh Tây Ninh | cbdMD (YCBD) Stock: Why Funds Hold It (Investors Pile In) 2026-04-18 - Community Volume Signals - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-04-18 | +2.5% | news | Cổng thông tin điện tử tỉnh Lào Cai | Is cbdMD (YCBD) stock positioned for growth (Eye on Rally) 2026-04-18 - Fed Rate Impact - Cổng thông tin điện tử tỉnh Lào Cai |
| 2026-02-17 | +2.5% | earnings | PR Newswire | cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026 |
| 2026-02-17 | +2.5% | earnings | Seeking Alpha | cbdMD, Inc. (YCBD) Q1 2026 Earnings Call Transcript |
| 2026-02-17 | +2.5% | earnings | Seeking Alpha | cbdMD GAAP EPS of -$0.04 beats by $0.02, revenue of $5M beats by $0.14M |
| 2026-02-17 | +2.5% | news | Stock Titan | CBD maker cbdMD buys Bluebird Botanicals as sales tick higher - Stock Titan |
| 2021-10-23 | -2.4% | news | Benzinga | cbdMD Stock Short Interest Report | AMEX:YCBD - Benzinga |
| 2025-05-13 | +2.4% | news | Intellectia AI | YCBD Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI |
| 2026-04-01 | -2.1% | expansion | PR Newswire | cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare |
| 2026-04-01 | -2.1% | legal | SEC EDGAR | YCBD 8-K: 5.02, 5.07 (SEC Filing) |
| 2026-04-01 | -2.1% | executive | Stock Titan | cbdMD (NYSE: YCBD) shareholders approve 2025 equity plan and 445,000-share CEO award - Stock Titan |
| 2026-04-01 | -2.1% | news | Stock Titan | Medicare opens a limited CBD pathway, and cbdMD builds a doctor channel - Stock Titan |
| 2022-08-17 | -1.8% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2021-08-20 | -1.7% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2024-06-07 | +1.6% | news | Seeking Alpha | cbdMD announces notification of noncompliance with NYSE American listing standards |
| 2021-07-16 | -1.6% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2026-04-15 | +1.6% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2026-04-15 | +1.6% | news | Stock Titan | cbdMD (NYSE: YCBD) grants RSUs and raises cash retainers for directors - Stock Titan |
| 2021-10-05 | -1.5% | legal | SEC EDGAR | YCBD 8-K: 5.02 and (SEC Filing) |
| 2023-05-19 | -1.4% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2021-08-18 | +1.4% | legal | SEC EDGAR | YCBD 8-K: 3.02 (SEC Filing) |
| 2025-12-08 | +1.2% | news | Seeking Alpha | cbdMD regains compliance with NYSE American listing standards |
| 2025-12-08 | +1.2% | legal | SEC EDGAR | YCBD 8-K: 7.01, 8.01 (SEC Filing) |
| 2023-07-21 | -1.2% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2025-05-21 | +1.1% | news | Stock Titan | THC Beverage Leader Herbal Oasis Captures $571M Market With Major Southeast Expansion - Stock Titan |
| 2024-05-15 | -1.0% | earnings | Seeking Alpha | cbdMD GAAP EPS of -$1.35, revenue of $4.4M |
| 2021-09-16 | -1.0% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2022-12-16 | -1.0% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2021-06-30 | +0.7% | legal | SEC EDGAR | YCBD 8-K: 1.01, 8.01 (SEC Filing) |
| 2023-08-10 | +0.7% | earnings | Seeking Alpha | cbdMD GAAP EPS of -$1.16, revenue of $6.12M |
| 2024-02-16 | +0.6% | news | Seeking Alpha | cbdMD files to sell 5.14M shares of common stock for holders |
| 2024-07-19 | +0.6% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2021-06-21 | -0.6% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2023-09-25 | +0.6% | legal | SEC EDGAR | YCBD 8-K: 8.01 and (SEC Filing) |
| 2025-06-04 | +0.5% | news | Intellectia AI | YCBD Forecast — Price Prediction for 2026. Should I Buy YCBD? - Intellectia AI |
| 2025-11-25 | +0.5% | legal | SEC EDGAR | YCBD 8-K: 2.02 and (SEC Filing) |
| 2025-01-10 | -0.4% | legal | SEC EDGAR | YCBD 8-K: 8.01 and (SEC Filing) |
| 2022-02-16 | -0.4% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2022-09-19 | +0.4% | legal | SEC EDGAR | YCBD 8-K: 8.01 (SEC Filing) |
| 2023-10-26 | +0.3% | legal | SEC EDGAR | YCBD 8-K: 8.01 and (SEC Filing) |
| 2024-06-10 | +0.2% | legal | SEC EDGAR | YCBD 8-K: 3.01, 8.01 (SEC Filing) |
| 2025-12-14 | +0.2% | news | StocksToTrade | cbdMD Inc. Surges on NYSE Compliance and Strategic Financial Moves - StocksToTrade |
| 2025-12-14 | +0.2% | earnings | timothysykes.com | cbdMD’s NYSE Compliance Resolved and Positive Revenue Forecast Ignites Optimism - timothysykes.com |
| 2025-12-13 | +0.2% | legal | StocksToTrade | cbdMD Strengthens Market Status with Regulatory Compliance - StocksToTrade |
| 2025-12-13 | +0.2% | news | timothysykes.com | cbdMD’s Stock Rebounds with Recent NYSE Compliance Achievements - timothysykes.com |
| 2023-10-28 | -0.1% | analyst | TradingView | YCBD Forecast — Price Target — Prediction for 2027 - TradingView |
| 2026-04-16 | -0.0% | news | Stock Titan | Board member at cbdMD (YCBD) receives 1,572-share stock grant - Stock Titan |
| 2026-04-16 | -0.0% | news | Stock Titan | cbdMD (YCBD) board member receives 1,572 RSUs as equity compensation - Stock Titan |
| 2026-04-16 | -0.0% | news | Stock Titan | Board member at cbdMD (YCBD) granted 1,572 restricted stock units - Stock Titan |
| 2026-04-16 | -0.0% | news | Stock Titan | cbdMD (YCBD) director Jeffrey Porter granted 1,572 RSUs, controls large indirect stake - Stock Titan |
| 2026-04-16 | -0.0% | news | Stock Titan | Director Bakari Sellers gets 1,572 cbdMD (YCBD) RSUs as board grant - Stock Titan |